Advertisement

Topics

Bracco Diagnostic Inc. Company Profile

00:04 EDT 20th June 2018 | BioPortfolio

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs.


News Articles [277 Associated News Articles listed on BioPortfolio]

Bracco Imaging reinforces its portfolio in Interventional Oncology

MILAN, March 3, 2018/PRNewswire/ -- Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today a strategic partnership with R.A.W. S.r.l. - an Read more...

Shanghai Pharma Extends Research Collaboration with Bracco Imaging

Shanghai Pharma has signed a new 20-year collaboration with Milan's Bracco Imaging to develop Bracco's microbubbles technology as an ultrasound contrast agent to image tumor angiogenesis. Microbubbles...

Bracco Imaging refuerza su cartera de oncología intervencionista

MILÁN, 4 de marzo de 2018 /PRNewswire/ -- Bracco Imaging S.p.A., líder mundial en dispositivos de diagnóstico por imagen, ha anunciado hoy una colaboración estratégica con Read more...

Bracco Imaging verstärkt sein Portfolio bei interventioneller Onkologie

MAILAND, 3. März 2018 /PRNewswire/ -- Bracco Imaging S.p.A., ein weltweit führendes Unternehmen bei diagnostischer Bildgebung, gab heute eine strategische Partnerschaft mit R.A.W. S.r.l. bekannt, ...

Bracco Imaging partners with R.A.W to expand interventional oncology portfolio

Bracco Imaging has partnered with Italian company R.A.W. to expand its portfolio of solutions for interventional oncology.

Bracco files patent infringement complaint against Jubilant for rubidium-82 generators

Bracco files patent infringement complaint against Jubilant for rubidium-82 generators moconnor Mon, 04/09/2018 - 17:20 Teaser Media

Bracco Imaging and Shanghai Pharmaceuticals join forces in the field of ultrasound

MILAN, May 22, 2018 /PRNewswire/ -- Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Shanghai Pharmaceuticals Holding Co. Ltd., a leading pharmaceutical gr...

Bracco Imaging SpA Medical Equipment Deals and Alliances Profile [Report Updated: 08022018] Prices from USD $250

SummaryBracco Imaging SpA Bracco, a subsidiary of Bracco SpA is a provider of diagnostic imaging solutions. The company offers diagnostic imaging, bracco pharma and health services. It offers solution...

Drugs and Medications [28 Associated Drugs and Medications listed on BioPortfolio]

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Chromitope sodium [BRACCO DIAGNOSTICS INC.]

CHROMITOPE Sodium Sodium Chromate Cr 51 Injection USP

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

PubMed Articles [1018 Associated PubMed Articles listed on BioPortfolio]

The diagnostic and cellularity yield of reverse bevel versus fork-tip fine needle biopsy.

Two new systems with a novel tip (Procore™ and SharkCore™) have been introduced for ultrasound-guided fine needle biopsy (US-FNB). Direct comparison of the diagnostic yield of these needles in the...

Comparative analysis of diagnostic scales of acute appendicitis: Alvarado, RIPASA and AIR.

Acute appendicitis is the most common surgical disease in emergency surgery, however, it remains a diagnostic problem and represents a challenge despite the experience and the different clinical and p...

Validation of diagnostic tests for histologic chorioamnionitis: Systematic review and meta-analysis.

The aim of this study was to determine the diagnostic performance of different diagnostic tests for histologic chorioamnionitis in patients at more than 20 weeks of gestation.

Improvement of diagnostic performance of pathologists by reducing the number of pathologists responsible for thyroid fine needle aspiration cytology: An institutional experience.

Various efforts have been made to improve the diagnostic accuracy of thyroid fine needle aspiration (FNA) cytology. We changed the diagnostic system by reducing the number of pathologists responsible ...

Diagnostic accuracy of antigen-based immunochromatographic rapid diagnostic tests for the detection of Salmonella in blood culture broth.

In low resource settings, Salmonella serovars frequently cause bloodstream infections. This study investigated the diagnostic performance of immunochromatographic rapid diagnostic tests (RDTs), which ...

Clinical Trials [1982 Associated Clinical Trials listed on BioPortfolio]

RIGENERA 2.0 Trial

Study Objectives: To determine whether, in patients with large acute myocardial infarction undergoing primary or rescue angioplasty, the administration of subcutaneous Lenograstim [recombi...

Diagnostic Agreement of iFR and QFR.

A Prospective, observational, single center diagnostic study to investigate the the diagnostic agreement between QFR and the pressure wire-based iFR in a real world setting.

Influence of Diagnostic Errors on the Prognosis of Acute Pulmonary Embolism

Diagnostic errors have been reported frequently in patient with pulmonary embolism since symptoms are not specific. However, there is only scarce evidence that the delay associated with di...

Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors

This clinical study is designed to evaluate the diagnostic performance of VisioCyt test, which would improve the early diagnosis of bladder cancer in order to optimize the management of in...

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

RATIONALE: New diagnostic procedures such as computed tomographic colonography may provide a less invasive method of identifying patients who have colorectal neoplasia. PURPOSE: Diagnosti...

Companies [988 Associated Companies listed on BioPortfolio]

Bracco Diagnostic Inc.

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging dev...

Bracco Diagnostics Inc.

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging dev...

Bracco Imaging S.p.A.

Bracco Imaging S.p.A. is one of the World’s leading companies in the diagnostic imaging business. Bracco Imaging develops, manufactures and markets diagnostic imaging agents ...

Bracco Diagnostics Inc

Bracco, founded in 1927 by the family who gave it its name and which has been at its helm for three generations and still runs it today, is an integrated Healthcare Group, world leader in global solut...

ACIST Medical Systems Inc.

ACIST Medical Systems, Inc. is a pioneering interventional and diagnostic technology company with a portfolio of advanced products, including the world’s first Rapid Exchange...

More Information about "Bracco Diagnostic Inc." on BioPortfolio

We have published hundreds of Bracco Diagnostic Inc. news stories on BioPortfolio along with dozens of Bracco Diagnostic Inc. Clinical Trials and PubMed Articles about Bracco Diagnostic Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bracco Diagnostic Inc. Companies in our database. You can also find out about relevant Bracco Diagnostic Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record